We are live on ! Find out more

665 hedge funds and large institutions have $21.6B invested in ResMed in 2020 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 242 increasing their positions, 228 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more call options, than puts

Call options by funds: $65.5M | Put options by funds: $43.8M

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

6% more funds holding

Funds holding: 628 → 665 (+37)

8% more capital inflows, than outflows

Capital inflows: $843M | Capital outflows: $781M

6% more repeat investments, than reductions

Existing positions increased: 242 | Existing positions reduced: 228

4% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 70

0.43% more ownership

Funds ownership: 69.58% → 70.01% (+0.43%)

Holders
665
Holders Change
+37
Holders Change %
+5.89%
% of All Funds
11.71%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.14%
New
73
Increased
242
Reduced
228
Closed
70
Calls
$65.5​M
Puts
$43.8​M
Net Calls
+$21.7​M
Net Calls Change
+$42.5​M

RMD Hedge Fund Activity: Q4 2020 in Review

665 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2020, worth a combined $21.6B — up 25% from $17.3B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new RMD positions and 70 closed out — a net gain of 3 holders — while 242 added to existing stakes and 228 trimmed.

The largest buyer was AKO Capital, opening a new position worth an estimated $71M. The largest seller was Zurich Insurance Group, cutting an estimated $65.5M.

  • 665 institutional investors held ResMed (RMD) as of Q4 2020, up from 628 in Q3 2020.
  • Funds reported $21.6B of ResMed stock for Q4 2020, up 25% quarter-over-quarter.
  • 73 funds opened new ResMed positions in Q4 2020 and 70 closed out, a net change of +3 holders.
  • The largest ResMed buyer in Q4 2020 was AKO Capital, an estimated $71M added.
  • The largest ResMed seller in Q4 2020 was Zurich Insurance Group, an estimated $65.5M sold.

Based on aggregated 13F filings for Q4 2020.